3: Open Source, Open Science

As the series nears its midway point we are learning about DNDi’s Open Synthesis Network.

05/02/2022

Subscribe for free:

As the series nears its midway point, we are going open source. First we’ll talk to Ben Perry and Andrea Vernall about DNDi’s Open Synthesis Network for drug discovery, and then we’ll venture into the academy to speak with one of the students contributing to the Network. Information wants to be free, man, so hit play and learn a thing or two!

Ben Perry
is the Discovery Open Innovation Leader for DNDi. He can be found on twitter at @MrBenGP

Andrea Vernall
is a Senior Lecturer in the Department of Chemistry at the University of Otago. She can be found on Twitter at @andreav_otago

Aaron Mothersole
is an MRes Drug Discovery and Development Researcher at Imperial College London.

Mentioned in the episode
•  the DNDi Open Synthesis Network
•  the open source philosophy and the open science philosophy
•  ‘Warhead’ molecules in cancer therapy

If you have thoughts on anything you heard in this episode and want to share them or contribute to the magazine, then drop me an email at [email protected]

Email*

Choose a password*

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the "Small Molecule" field I want to stay up to date with the Cell and Gene field I want to stay up to date with the Bioprocessing field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

All Episodes

3: Open Source, Open Science

4: The Cutting Edge

2: Neglected Diseases, and How to Beat Them

1: Who are the DNDi?